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Aim: Transcatheter aortic valve implantation (TAVI) has become an important treatment
option for older patients with severe aortic stenosis. However, not all patients benefit from
this procedure in terms of functional outcome and quality of life. This complicates patient
selection and shared decision-making. Postoperative delirium might negatively affect patient
outcomes after TAVI. We therefore studied the potential relationship between postoperative
delirium and functional outcome, and how this impacts quality of life after TAVI.
Methods: This was a prospective cohort study of 91 consecutive patients undergoing TAVI
between 2015 and 2017 at an academic medical center. All patients underwent a Comprehen-
sive Geriatric Assessment before TAVI. Delirium symptoms were assessed daily during hospi-
talization. Follow up was carried out between 6 and 12 months postprocedure. The primary
outcome was functional decline or death at follow up. Secondarily, we measured quality of life
at follow up.
Results: The incidence of postoperative delirium was 15.4%. In total, 38.5% of patients
experienced functional decline, and 11.0% died during a median follow-up period of
7 months. Delirium resulted in a fourfold increased odds of the combined outcome of func-
tional decline or death. Quality of life was lower in patients that experienced this outcome.
Conclusion: In a cohort of TAVI patients, functional decline or death was a frequent out-
come in the first year postprocedure. Postoperative delirium increased the odds for this out-
come substantially. This suggests that delirium risk should be an important factor to consider
in shared decision-making for TAVI patients. Geriatr Gerontol Int 2020; ••: ••–••.
Keywords: activities of daily living, cardiovascular surgery, delirium, quality of life, trans-
catheter aortic valve implantation.
Introduction
Degenerative valvular aortic stenosis is a common medical condi-
tion of older age. Severe symptomatic aortic stenosis has a poor
prognosis if left untreated, with an annual mortality rate of up to
50%.1,2 For many patients, a conventional surgical aortic valve
replacement is not suitable due to high surgical risk. With the intro-
duction of the transcatheter aortic valve implantation (TAVI), a less
invasive therapeutic option became available for high-risk patients
that reduces mortality similar to surgical aortic valve replacement.3
More recently, older patients with intermediate surgical risk, and
sometimes even with low risk, are also considered for TAVI.4,5
Selecting patients who will benefit from this procedure is a topic
of debate. The Society of Thoracic Surgeons score and the
European System for Cardiac Operative Risk Evaluation, which are
used for patients undergoing conventional cardiac surgery, have
proven to be less accurate in predicting mortality for patients being
considered for TAVI.6 Also, for older patients, survival is often not
the most important health outcome, and many regard “remaining
independent” equally or more important.7 However, previous
research has shown that a subgroup of patients does not benefit
from TAVI in terms of functional improvement or quality of life.8,9
Up to 44% of TAVI patients experience postoperative delir-
ium.10 Previous research suggests that delirium might result in a
higher chance of functional decline in the first year after
TAVI.11,12 How postoperative delirium and functional outcome
influence quality of life in TAVI patients is unknown. This is vital
information for cardiologists, geriatricians and patients to make an
informed decision.
We therefore aimed to study a potential relationship between
postoperative delirium and functional outcome within the first
year after the procedure, and how this reflects on quality of life
after TAVI, to improve patient selection and shared decision-
making for older TAVI patients.
Methods
Study design and population
We carried out an observational prospective cohort study between
July 2015 and December 2017. We included consecutive patients
DOI: 10.1111/ggi.14064
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who underwent elective TAVI at a university teaching and tertiary
hospital in the Netherlands, and were able and willing to partici-
pate in a follow-up visit after 6–12 months. There were no exclu-
sion criteria. All patients were evaluated by a multidisciplinary
heart team comprising invasive cardiologists, imaging cardiologists
and cardiothoracic surgeons, as well as a geriatrician to establish
the indication and suitability for TAVI. Permission was granted by
the local Medical Ethics Committee.
Baseline assessments
At baseline, patients were evaluated at the geriatric outpatient
clinic by a comprehensive geriatric assessment (CGA), to optimize
patient selection and the perioperative trajectory. During this
CGA, information regarding demographic data, social status, cur-
rent health status, comorbidities, medication use, laboratory
results, cognitive and functional status was gathered. We used the
Charlson Comorbidity Index to list comorbidities.13 Cognitive
screening was carried out with the Mini-Mental State Examina-
tion.14 Patients were asked if they experienced a previous delirium.
For functional status, two different questionnaires were used.
During the first year of the study, the Groningen Activity Restric-
tion Scale (GARS-4) was used.15 This scale comprises 11 items
regarding activities of daily living (ADL) and seven items regarding
instrumental activities of daily living (iADL). Each item is scored
on four levels: independent without difficulty,1 independent with
some difficulty,2 independent with much difficulty3 or depen-
dent.4 This scale can be recoded into a dichotomous outcome:
independent (level 1–3) or dependent (level 4), which is how it was
used in the present analysis (thus named GARS-2). During the
rest of the study period the 15-item modified Katz Index of Activi-
ties of Daily Living (Katz-ADL 15) was used.16 This scale consists
of eight ADL and seven iADL items, scored as dependent or inde-
pendent. Functional dependency was scored as the number of
items in which the participant was dependent, on either the
GARS-2 or Katz-ADL 15.
Assessments during hospitalization
A team of experienced geriatric nurses and geriatricians assessed
delirium daily during weekdays using the criteria from the Diagnos-
tic and Statistical Manual of Mental Disorders, Fifth Edition.17 Non-
pharmacological measures to prevent delirium were implemented
according to the hospital protocol for all patients with an
increased delirium risk, as assessed during the CGA. Delirium was
treated according to the hospital protocol. Perioperative complica-
tions were recorded according to the Valve Academic Research
Consortium-2 consensus document.18
Follow-up assessment of functional status and quality
of life
All patients had several follow-up visits at the cardiology depart-
ment planned during the first year postprocedure. They were
called in advance to ask if they were willing to participate in a geri-
atric follow-up measurement at one of these appointments, prefer-
ably at 6 months postprocedure. Functional status was assessed
using the Katz-ADL15 or GARS-2, depending on which scale was
used at baseline. Functional decline was defined as an increase of
at least 1 point on the Katz-ADL 15 or GARS-2 at follow up com-
pared with baseline. Patients who died before follow up could take
place were also included in the analysis, resulting in the combined
outcome of functional decline or death as the primary outcome of
interest.
Health-related quality of life was measured using the
EuroQuol-5D (EQ-5D). The EQ-5D consists of five domains
(mobility, self-care, usual activities, pain/discomfort and anxiety/
depression), which are scored on three levels: (i) no problems;
(ii) some problems; or (iii) extreme problems. A single index value
was generated by aggregating and weighting the five domains,
using de Dutch EQ-5D tariff.19 The resulting score ranges from
<0 (0 is a health state equivalent to death, negative values are val-
ued as “worse than death”) to 1 (perfect health). The EQ-5D
visual analog scale (VAS), ranging from 0 to 100 (higher score
indicating better health) was used to measure patients’ perceived
general health status.
Statistical analysis
SPSS version 23.0 (IBM Corporation, Armonk, NY, USA) was used
for data analysis. Differences in baseline characteristics and
postoperative outcomes between participants with and without
delirium were assessed using t-tests, χ2-tests or Mann–Whitney
U-tests.
A logistic regression was carried out with the combined out-
come variable of functional decline or death as the dependent var-
iable, and delirium as the independent variable. To assess the
possible causal association between delirium and the combined
outcome variable, we used the method of directed acyclic graphs
(DAG) to establish confounders of this causal pathway.20 A DAG
is a graph using unidirectional arrows to represent known causal
effects between variables (on the basis of prior knowledge). The
arrows between variables form paths. Depending on the direction
of the arrows, different types of paths are formed, which in turn
identify which variable is a confounder, collider or mediator of the
causal pathway of interest. Based on our DAG, age, baseline func-
tional dependence and Mini-Mental State Examination, the num-
ber of comorbidities and perioperative complications were
identified as confounders, and were thus added as covariates to
our model (Fig. SS1).
Results
Patient recruitment and baseline data
During the study period, 100 consecutive patients were eligible to
participate in the study. One patient had an incomplete functional
assessment at baseline, five patients declined follow up, two
patients were not able to participate in follow up due to poor con-
dition and one patient was lost to follow up, resulting in
91 patients that were included in the present study. During a
median follow-up period of 7 months (interquartile range [IQR]
6.0–10.0 months), 35 patients experienced functional decline
(38.5%) and 10 patients died (11.0%; Fig. 1).
The baseline characteristics of the 91 included patients are
described in Table 1, subdivided by delirium status. As shown
by the European System for Cardiac Operative Risk Evalua-
tion, 18.7% had low, 56.0% had intermediate and 25.3% had
high surgical risk. During hospitalization, 14 patients (15.4%)
experienced delirium. Patients with delirium more often had
experienced prior delirium, had a lower Mini-Mental State
Examination score and had poorer kidney function at baseline
than patients without delirium. They also appeared to have a
lower baseline functional status, but the difference was not sta-
tistically significant.
SJ Beishuizen et al.
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Procedural and postprocedural outcomes
All but one patient received general anesthesia. The access
route for TAVI was transfemoral in 75 (82.4%) patients.
Patients with delirium more often had a non-transfemoral
approach than patients without delirium, but this difference
was not statistically significant (46.7% and 13.0%, respec-
tively, P = 0.07). Table 2 shows the procedural and post-
procedural outcomes of patients with and without delirium.
The number of Valve Academic Research Consortium-2 com-
plications and in-hospital mortality were comparable between
groups. During the median follow-up period of 7 months,
death and functional decline were more frequent in patients
with delirium (28.6% and 50.0%, respectively), than in
patients without delirium (7.8% and 36.4%, respectively),
although the latter difference between groups was not statisti-
cally significant. The combined outcome of functional decline
or death occurred in 45 patients, and was more frequent in
patients with delirium, than in patients without (78.6%
vs 44.2%).
Functional decline or death and the association with
delirium
In multivariate analysis, postoperative delirium was associated with
an increased odds of functional decline or death (odds ratio 4.75,
95% confidence interval 1.10–20.43). All other covariates showed
no significant association with the outcome (Table 3).
Quality of life and the association with functional decline
Results of the EQ-5D were available for the 81 patients that sur-
vived until the follow-up visit. For the entire cohort, the median
EQ-5D index was 0.81 (IQR 0.65–0.89) and the mean EQ VAS
was 70.0 (IQR 60.0–75.0). When comparing EQ-5D scores of
patients with and without functional decline, both the index score
and VAS were lower in patients with functional decline than
patients without functional decline (Table 4). On the individual
EQ-5D items, patients with functional decline had lower scores
on the items “mobility” and “self-care”(Table 4).
Figure 1 Enrollment and follow up
of patients.
Table 1 Baseline characteristics of patients with and without delirium
Variable Delirium (n = 14) No delirium (n = 77) P-value
Age (mean ± SD) 83.6 ± 4.0 80.4. ± 6.1 0.06
Male, n (%) 7 (50.0) 30 (39.0) 0.44
Living at home, n (%) 11 (78.6) 68 (89.5) 0.25
No or only primary education, n (%) 7 (50.0) 29 (38.6) 0.43
No. iADL dependencies, median (IQR) 4.0 (0.75–7.5) 2.0 (0.0–4.5) 0.17
Subjective memory complaints, n (%) 7 (50.0) 23 (29.9) 0.15
Data missing 0 1
Prior delirium, n (%) 7 (50.0) 10 (13.0) <0.001
MMSE, median (IQR) 27.0 (24.8–28.2) 28.0 (27.0–29.0) 0.05
Data missing 0 1
Charlson Comorbidity Index, median (IQR) 2.0 (1.0–2.5) 2.0 (1.0–3.0) 0.98
No. prescriptions, median (IQR) 9.5 (6.8–12.5) 8.0 (5.5–11.0) 0.27
Logistic EuroSCORE I, median (IQR) 19.0 (12.9–22.3) 15.0 (10.0–19.0) 0.12
Left ventricular ejection fraction in %, median
(IQR)
47.5 (40.0–55.0) 55.0 (45.0–55.0) 0.64
Atrial fibrillation (%) 6 (42.9) 27 (35.1) 0.58
eGFR, mean mL/min/1.73 m2 (SD) 57.7 (17.2) 47.1 (8.2) 0.03
Hb, mean mmol/L (SD) 7.8 (0.8) 8.1 (1.1) 0.38
ADL, activities of daily living; eGFR, estimated glomerular filtration rate; Hb, hemoglobin; iADL, instrumental activities of daily living; IQR, inter-
quartile range; MMSE, Mini-Mental State Examination; SD, standard deviation.
TAVI, delirium and functional decline
© 2020 The Authors. Geriatrics & Gerontology International
published by John Wiley & Sons Australia, Ltd on behalf of Japan Geriatrics Society.
| 3
Discussion
In this observational study of 91 consecutive TAVI patients, we
found that postoperative delirium resulted in a fourfold increased
odds for functional decline or death in the first year
postprocedure. Functional decline occurred in over one-third of
patients when measured after a median follow-up period of
7 months, and these patients experienced a lower quality of life
than patients with a stable or improved functional status. The pre-
sent results emphasize that TAVI, although a less invasive treat-
ment option for severe aortic stenosis, still results in a poor
functional outcome in a substantial number of patients, and that
delirium risk should be an important factor to consider in shared
decision-making.
We found that a large portion of patients (38.5%) experienced
functional decline after TAVI. When measuring functional out-
come after TAVI, previous research mostly reported a clinically
important improvement in New York Heart Association class,
corresponding to fewer limitations in physical activities due to
heart failure symptoms.9 However, given that the estimates of
change in these studies often show a lower end of the 95%
confidence interval near 0, this indicates that a proportion of
patients fail to improve. Measuring the mean change in New York
Heart Association class in an entire cohort does not provide infor-
mation on this latter subgroup, nor on individual domains of
functional capacity. A more specific way of evaluating functional
status is by measuring individual ADL and iADL limitations. In a
cohort of 143 TAVI patients, 22.9% of patients had a trajectory
with moderate-to-large functional decline, and 19.4% of patients
showed only minimal decline during the first 12 months
postprocedure. The remaining 37.1% had full functional recovery
after TAVI.21 This is comparable to the present findings. In
another cohort of 106 patients, 20.8% had a decrease of ≥1 point
on an ADL scale 6 months after TAVI.22 In this study of Scho-
enenberger et al.,22 iADL activities were not measured, which
could explain the lower incidence of functional decline. Including
limitations on both ADL and iADL in the definition of functional
decline might be more sensitive to detect change.
We found that 15.4% of patients developed delirium, and that
patients with delirium had a fourfold increased odds of experienc-
ing functional decline or dying during follow up. Evidence on the
association between delirium and functional decline in the TAVI
population is scarce and shows inconsistent findings. In a cohort
of 110 TAVI patients, 25.5% of patients experienced delirium,
and severe delirium was associated with poor ADL and iADL
recovery or death after 6 and 12 months, but this was not the case
for mild delirium.12 In a cohort of 63 TAVI patients with a higher
delirium incidence of 44%, delirium predicted lower ADL and
iADL score 1 month after TAVI, but at 6 months’ follow up this
was no longer the case.11 The different findings of this latter study
might be explained by the fact that deceased patients were not
included in the primary analyses, which could have introduced
survival bias. Overall, the present results add to the limited body
of evidence that delirium after TAVI is an important predictor of
poor functional outcome, including death.
Previous research found that frailty, comorbidity and route of
procedure were also associated with poor outcome in TAVI
patients.22–24 We could not replicate these findings. We did not
include an overall frailty measure in our model, because it was not
part of the CGA before TAVI; and route of procedure was not
included, because according to our DAG it was a mediator of the
Table 2 Procedural and postprocedural outcomes of patients with and without delirium
Variable Delirium (n = 14) No delirium (n = 77) P-value
Complications, n (%)
Myocardial infarction 0 (0) 0 (0) n.a.
Stroke 0 (0) 2 (2.6) 0.54
Bleeding 4 (28.6) 24 (31.2) 0.85
Vascular 2 (14.3) 12 (15.6) 0.77
Acute kidney injury 1 (7.1) 4 (5.2) 0.77
Need for a pacemaker 0 (0) 10 (13.0) 0.15
Length of hospital stay in days, median (IQR) 7.5 (6.8–15.0) 7.0 (6.0–8.0) 0.05
Functional decline† 7 (50.0) 28 (36.4) 0.07
Data missing‡ 4 6
Mortality
In hospital 1 (4.1) 3 (3.9) 0.59
During follow up 4 (28.6) 6 (7.8) 0.02
Functional decline or death 11 (78.6) 34 (44.2) 0.02
†Increase of at least one point on the 15-item modified Katz Index of Activities of Daily Living or Groningen Activity Restriction Scale at follow up
compared with baseline.
‡All cases are missing due to death at the time of measurement.
IQR, interquartile range.
Table 3 Results from multivariate analysis, effect of delirium on
outcome functional decline or death
Factor P-value Odds ratio (95%CI)
Delirium 0.04 4.75 (1.10–20.43)
Age 0.24 1.05 (0.97–1.14)
Baseline MMSE 0.48 0.92 (0.74–1.16)
Baseline iADL dependencies† 0.59 0.95 (0.79–1.14)
Charlson Comorbidity Index 0.87 0.98 (0.74–1.30)
No. VARC-2 complications‡ 0.12 2.14 (0.82–5.64)
†Number of dependencies on either 15-item modified Katz Index of
Activities of Daily Living or Groningen Activity Restriction Scale.
‡Myocardial infarction, cerebrovascular event, vascular, hemorrhage,
acute kidney injury or need for pacemaker implantation.
CI, confidence interval; iADL, instrumental activities of daily living;
MMSE, Mini-Mental State Examination; VARC-2, Valve Academic
Research Consortium-2.
SJ Beishuizen et al.
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association between delirium and outcome, and not a potential
confounder (Fig. SS1). The reason that individual frailty domains,
such as cognition, functional dependency and comorbidity, were
not significant in our model might be due to selection bias. The
present cohort consisted of patients who were evaluated and
approved for TAVI by the heart team, and patients who under-
went surgical aortic valve replacement or medical treatment were
thus excluded. This might have resulted in more homogeneity in
these variables and thus no significant association in our model.
Quality of life was satisfactory in the present cohort, although
lower scores were found in patients with functional decline. Nor-
mal values for Dutch persons of aged ≥75 years on the EQ-5D
index and VAS are 0.83 and 72.9, respectively, which are slightly
higher than the scores in our cohort.25 To our knowledge, the
association between functional outcome and quality of life has not
been studied before in TAVI patients.
There were some limitations to the present study. First, in the
study population, all but one patient received general anesthesia.
TAVI is a rapidly evolving treatment, and anesthesia is currently
more often carried out locally or with sedation instead of general
anesthesia.26 This might have influenced our findings, although
existing literature has not identified a clear causal association
between type of anesthesia and postoperative delirium or mortal-
ity.27,28 Second, two different instruments were used to measure
ADL and iADL. These instruments are similar, although there are
differences both with respect to the number of items (Katz-
ADL15 consists of 15 items and GARS-2 of 18) and the content
of the items. Therefore, a 1-point change on the Katz-15 is not
exactly the same as on the GARS-2. Finally, there was a difference
in follow-up time between patients. However, the spread in
follow-up duration was small (IQR 6.0–10.0 months), so we do
not expect that this has impacted the present findings
substantially.
A strength of the present study was that this was a real-life
cohort with no exclusion criteria, that accurately describes daily
clinical practice. Also, a complete CGA was carried out at baseline,
and during hospitalization delirium assessment was carried out
daily by a specialist team of geriatricians and geriatric nurses,
which has resulted in high-quality data. Finally, by using a DAG,
we systematically addressed confounding and made a stronger
argument for the possible causal association between delirium and
functional decline or death, than would have resulted from a sta-
tistically based method.
In conclusion, in the present study of 91 TAVI patients, we
found that over one-third of patients experienced functional
decline, and one out of 10 patients had died after a median
follow-up period of 7 months. Delirium was an important risk fac-
tor for the combined outcome functional decline or death. Quality
of life was lower in patients with functional decline than in
patients with a stable functional status or improvement. Delirium
risk should be incorporated in the process of shared decision-
making, and delirium prevention should remain a top priority in
TAVI patients. Future studies that address patients goals for
TAVI, and whether or not they were met after treatment, in rela-
tion to functional outcome, could further improve decision-
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Supporting Information
Additional supporting information may be found in the online
version of this article at the publisher’s website:
Figure S1. Directed acyclic graphs (DAG) that were used for the
analysis of the possible causal association between delirium and
the combined outcome variable functional decline or death (bold
arrow). Each arrow represents a causal effect. (a) All possible asso-
ciations between variables. Continuous arrows form paths that
can result in confounding. Dotted arrows form paths that can
result in other types of bias (mediation, colliding for example).
(b) Only paths that result in confounding and thus identify the
variables that were used in the final analysis. For example the vari-
able age has a causal association with both delirium and the com-
bined outcome functional decline or death, and is therefore a
confounder.
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